References
- Vankemmelbeke M Chua JX Durrant LG . Cancer cell associated glycans as targets for immunotherapy . Oncoimmunology5 ( 1 ), e1061177 ( 2016 ).
- Belaya K Finlayson S Slater CR et al. Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates . Am. J. Human Genetics91 ( 1 ), 193 – 201 ( 2012 ).
- Hou H Sun H Lu P et al. Tunicamycin potentiates cisplatin anticancer efficacy through the DPAGT1/Akt/ABCG2 pathway in mouse xenograft models of human hepatocellular carcinoma . Mol. Cancer Ther.12 ( 12 ), 2874 – 2884 ( 2013 ).
- Yoo J Mashalidis EH Kuk A et al. GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation . Nat. Struct. Mol. Biol.25 ( 3 ), 217 – 224 ( 2018 ).
- Dong YY Wang H Pike AC et al. Structures of DPAGT1 explain glycosylation disease mechanisms and advance TB antibiotic design . BioRobix175 ( 4 ), 1045 – 1058 ( 2018 ).
- Jeanes A Gottardi CJ Yap AS . Cadherins and cancer: how does cadherin dysfunction promote tumor progression?Oncogene27 ( 55 ), 6920 – 6929 ( 2008 ).
- Sengupta PK Bouchie MP Kukuruzinska MA . N-glycosylation gene DPAGT1 is a target of the Wnt/β-catenin signaling pathway . J. Biol. Chem.285 ( 41 ), 31164 – 31173 ( 2010 ).
- Huang SH Wang DI Zhang SH et al. Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer . Cancer Chemother. Pharmacol.80 ( 4 ), 685 – 696 ( 2017 ).
- Banerjee A Martinez J Longas M et al. N-acetylglucosaminyl 1-phosphate transferase: an excellent target for developing new generation breast cancer therapeutic . Advances Exper. Med. Biol.842 , 355 – 374 ( 2015 ).
- Nami B Donmez H Kocak N . Tunicamycin-induced endoplasmic reticulum stress reduces in vitro subpopulation and invasion of CD44+/CD24-phenotype breast cancer stem . Cells68 ( 7 ), 419 – 426 ( 2016 ).
- Kartha VK Alamoud KA Sadykov K et al. Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer . Genome Med.10 ( 54 ), 1 – 18 ( 2018 ).
- Nita-Lazar M Rebustini I Walker J et al. Hypoglycosylated E-cadherin promotes the assembly of tight junctions through the recruitment of PP2A to adherens junctions . Experimental Cell Res.316 ( 11 ), 1871 – 1884 ( 2010 ).
- Lim E Jin H Jeonghoon K et al. Tunicamycin promotes apoptosis in leukemia cells through ROS generation and downregulation of surviving expression . Apoptosis20 ( 8 ), 1087 – 1098 ( 2015 ).
- Katsuhiko M Siricilla S Yang D et al. Fluorescence-based assay for polyprenyl phosphate-GlcNAc-1-phosphate transferase (WecA) and identification of novel antimycobacterial WecA inhibitors . Anal. Biochem.512 , 78 – 90 ( 2016 ).
- Katsuhiko M Yun HG Kurosu SM et al. Novel FR-900493 analogs that inhibit outgrowth of Clostridium difficile spores . ACS Omega3 ( 2 ), 1726 – 1739 ( 2018 ).
- de-Freitas-Junior JCM Bastos LG Freire-Neto CA et al. N-Glycan biosynthesis inhibitors induce in vitro anticancer activity in colorectal cancer cells . J. Cellular Biochem.113 ( 9 ), 2957 – 2966 ( 2012 ).
- Kurosu M . Inhibition of N-glycosylation towards novel anti-cancer chemotherapeutics . J. Mol Pharm. Org. Process Res.6 ( 1 ), 141 – 143 ( 2018 ).
- Katsuhiko M Eslamimehr S Kurosu S et al. N-glycosylation inhibitors towards novel anti-cancer chemotherapeutics . Abstracts of Papers, 256th ACS National Meeting Exposition , Boston, MA, USA , 19–23 August2018 .
- Mitachi K Kurosu S Eslamimehr S et al. A Semisynthesis of an anticancer DPAGT1 inhibitor from a muraymycin biosynthetic intermediate . Org. Lett.21 ( 4 ), 876 – 879 ( 2019 ).